Death-associated protein kinase phosphorylates mammalian ribosomal protein S6 and reduces protein synthesis
- PMID: 17087515
- PMCID: PMC4404312
- DOI: 10.1021/bi060413y
Death-associated protein kinase phosphorylates mammalian ribosomal protein S6 and reduces protein synthesis
Abstract
Death-associated protein kinase (DAPK) is a pro-apoptotic, calcium/calmodulin-regulated protein kinase that is a drug discovery target for neurodegenerative disorders. Despite the potential profound physiological role of DAPK in neuronal function and pathophysiology, the endogenous substrate(s) of this kinase and the mechanisms via which DAPK elicits its biological action remain largely unknown. We report here that the mammalian 40S ribosomal protein S6 is a DAPK substrate. Results from immunoprecipitation experiments are consistent with endogenous DAPK being associated with endogenous S6 in rat brain. When S6 is a component of the 40S ribosomal subunit complex, DAPK selectively phosphorylates it at serine 235, one of the five sites in S6 that are phosphorylated by the S6 kinase family of proteins. The amino acid sequence flanking serine 235 matches the established pattern for DAPK peptide and protein substrates. Kinetic analyses using purified 40S subunits revealed a K(m) value of 9 microM, consistent with S6 being a potential physiological substrate of DAPK. This enzyme-substrate relationship has functional significance. DAPK suppresses translation in rabbit reticulocyte lysate, and treatment of neuroblastoma cells with a stimulator of DAPK reduces protein synthesis. In both cases, suppression of translation correlates with increased phosphorylation of S6 at serine 235. These results demonstrate that DAPK is a S6 kinase and provide evidence for a novel role of DAPK in the regulation of translation.
Figures





Similar articles
-
A calmodulin-regulated protein kinase linked to neuron survival is a substrate for the calmodulin-regulated death-associated protein kinase.Biochemistry. 2004 Jun 29;43(25):8116-24. doi: 10.1021/bi049589v. Biochemistry. 2004. PMID: 15209507
-
Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein.Exp Cell Res. 2004 Apr 15;295(1):173-82. doi: 10.1016/j.yexcr.2003.12.021. Exp Cell Res. 2004. PMID: 15051500
-
A high throughput proteomics screen identifies novel substrates of death-associated protein kinase.Mol Cell Proteomics. 2008 Jun;7(6):1089-98. doi: 10.1074/mcp.M700579-MCP200. Epub 2008 Feb 18. Mol Cell Proteomics. 2008. PMID: 18283219
-
The DAP-kinase family of proteins: study of a novel group of calcium-regulated death-promoting kinases.Biochim Biophys Acta. 2002 Nov 4;1600(1-2):45-50. doi: 10.1016/s1570-9639(02)00443-0. Biochim Biophys Acta. 2002. PMID: 12445458 Review.
-
Structure, activity, regulation, and inhibitor discovery for a protein kinase associated with apoptosis and neuronal death.Pharmacol Ther. 2002 Feb-Mar;93(2-3):217-24. doi: 10.1016/s0163-7258(02)00190-0. Pharmacol Ther. 2002. PMID: 12191613 Review.
Cited by
-
Structural insight into nucleotide recognition by human death-associated protein kinase.Acta Crystallogr D Biol Crystallogr. 2009 Mar;65(Pt 3):241-8. doi: 10.1107/S0907444908043679. Epub 2009 Feb 20. Acta Crystallogr D Biol Crystallogr. 2009. PMID: 19237746 Free PMC article.
-
RETRACTED: Identification of phosphorylated p38 as a novel DAPK-interacting partner during TNFalpha-induced apoptosis in colorectal tumor cells.Am J Pathol. 2009 Aug;175(2):557-70. doi: 10.2353/ajpath.2009.080853. Epub 2009 Jul 23. Am J Pathol. 2009. Retraction in: Am J Pathol. 2017 Jan;187(1):225. doi: 10.1016/j.ajpath.2016.09.019. PMID: 19628771 Free PMC article. Retracted.
-
Targeting protein kinases in central nervous system disorders.Nat Rev Drug Discov. 2009 Nov;8(11):892-909. doi: 10.1038/nrd2999. Nat Rev Drug Discov. 2009. PMID: 19876042 Free PMC article. Review.
-
Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma.Acta Pharmacol Sin. 2019 Feb;40(2):268-278. doi: 10.1038/s41401-018-0020-z. Epub 2018 May 18. Acta Pharmacol Sin. 2019. PMID: 29777202 Free PMC article.
-
Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?Int J Mol Sci. 2021 Dec 21;23(1):48. doi: 10.3390/ijms23010048. Int J Mol Sci. 2021. PMID: 35008473 Free PMC article. Review.
References
-
- Schumacher AM, Velentza AV, Watterson DM. Death associated protein kinase as a potential therapeutic target. Expert Opin. Ther. Targets. 2002;6:497–506. - PubMed
-
- Velentza AV, Wainwright MS, Zasadzki M, Mirzoeva S, Schumacher AM, Haiech J, Focia PJ, Egli M, Watterson DM. An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase attenuates hypoxia-ischemia induced acute brain injury. Bioorg. Med. Chem. Lett. 2003;13:3465–3470. - PubMed
-
- Henshall DC, Araki T, Schindler CK, Shinoda S, Lan J-Q, Simon RP. Expression of death-associated protein kinase and recruitment to the tumor necrosis factor signaling pathway following brief seizures. J. Neurochem. 2003;86:1260–1270. - PubMed
-
- Craft JM, Watterson DM, Frautschy SA, Van Eldik LJ. Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo. Neurobiol Aging. 2004;25:1283–1292. - PubMed
-
- Shamloo M, Soriano L, Wieloch T, Nikolich K, Urfer R, Oksenberg D. Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia. J. Biol. Chem. 2005;280:42290–42299. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases